Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Next generation sequencing and WIN therapeutics
Dr Michael Pellini – Foundation Medicine, Cambridge, USA
Next generation sequencing and WIN therapeutics ( Dr Michael Pellini – Foundation Medicine, Cambridge, USA )
6 Jul 2012
Identifying targets with systems medicine
Dr Leroy Hood – Institute for Systems Biology, USA
Identifying targets with systems medicine ( Dr Leroy Hood – Institute for Systems Biology, USA )
6 Jul 2012
Importance of early detection and the ‘Beyond the Shock’ programme
Dr Douglas Feil – National Breast Cancer Foundation, USA
Importance of early detection and the ‘Beyond the Shock’ programme ( Dr Douglas Feil – National Breast Cancer Foundation, USA )
6 Jul 2012
Shortening the timeline for clinical drug developments
Dr James Doroshow – National Cancer Institute, Bethesda, USA
Shortening the timeline for clinical drug developments ( Dr James Doroshow – National Cancer Institute, Bethesda, USA )
6 Jul 2012
Building international collaborations and the WINTHER trial
Dr Oliver Bogler – MD Anderson Cancer Center, Houston, USA
Building international collaborations and the WINTHER trial ( Dr Oliver Bogler – MD Anderson Cancer Center, Houston, USA )
6 Jul 2012
Identifying drug sensitivity and resistance in acute myeloid leukaemia
Dr Mark Frattini – Memorial Sloan-Kettering Cancer Center, New York, USA
Identifying drug sensitivity and resistance in acute myeloid leukaemia  ( Dr Mark Frattini – Memorial Sloan-Kettering Cancer Center, New York, USA )
27 Jun 2012
Mouse models and proteomics tackling acute lymphoblastic leukaemia
Prof Jean-Pierre Bourquin - University Children's Hospital Zurich, Switzerland
Mouse models and proteomics tackling acute lymphoblastic leukaemia ( Prof Jean-Pierre Bourquin - University Children's Hospital Zurich, Switzerland )
25 Jun 2012
Assessing iron overload and toxicity
Prof John Porter - University College London, UK
Assessing iron overload and toxicity ( Prof John Porter - University College London, UK )
25 Jun 2012
BRCA carrier status as a prognostic factor for prostate cancer
Dr Elena Castro - The Institute of Cancer Research, Sutton, UK
BRCA carrier status as a prognostic factor for prostate cancer ( Dr Elena Castro - The Institute of Cancer Research, Sutton, UK )
20 Jun 2012
Effects of age on treatment and outcomes in women with stage IB-IIB cervical can...
Dr Don Dizon – Brown University, Providence, USA
Effects of age on treatment and outcomes in women with stage IB-IIB cervical cancer ( Dr Don Dizon – Brown University, Providence, USA )
19 Jun 2012
Novel PET tracers and their future use in assessment of response to treatment
Dr Andrei Iagaru – Stanford University, CA, USA
Novel PET tracers and their future use in assessment of response to treatment ( Dr Andrei Iagaru – Stanford University, CA, USA )
17 Jun 2012
Role of family history and genetic testing in diagnosis
Dr Marie Wood – University of Vermont, Burlington, USA
Role of family history and genetic testing in diagnosis  ( Dr Marie Wood – University of Vermont, Burlington, USA )
15 Jun 2012